Legend Biotech Corp (LEGN)
44.43
-0.74
(-1.64%)
USD |
NASDAQ |
Apr 25, 16:00
44.43
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Profit Margin (Quarterly): -182.2% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -182.2% |
| September 30, 2023 | -64.79% |
| June 30, 2023 | -271.6% |
| March 31, 2023 | -308.5% |
| December 31, 2022 | -491.7% |
| September 30, 2022 | -310.5% |
| June 30, 2022 | -1.61K% |
| March 31, 2022 | -64.53% |
| December 31, 2021 | -586.3% |
| September 30, 2021 | -742.8% |
| Date | Value |
|---|---|
| June 30, 2021 | -452.6% |
| March 31, 2021 | |
| December 31, 2020 | -51.67% |
| September 30, 2020 | -566.5% |
| June 30, 2020 | -1.16K% |
| March 31, 2020 | -383.1% |
| December 31, 2019 | -328.8% |
| September 30, 2019 | -157.3% |
| June 30, 2019 | -285.5% |
| March 31, 2019 | -123.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.61K%
Minimum
Jun 2022
-51.67%
Maximum
Dec 2020
-445.8%
Average
-319.6%
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 25.04% |
| Bristol-Myers Squibb Co | 15.35% |
| 2seventy bio Inc | -531.8% |
| Gilead Sciences Inc | 20.09% |
| Exelixis Inc | 17.83% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.03% |
| Return on Assets | -31.76% |
| Return on Invested Capital | -38.39% |
| Gross Profit Margin (Quarterly) | 59.16% |
| Operating Margin (Quarterly) | -150.8% |
| Return on Net Operating Assets | -129.1% |